Beacon Biosignals
Boston, US · Founded 2019 · Delaware corporation · 8 known investors
Founders & leadership
Beacon Biosignals was founded in 2019 by Jacob A. Donoghue, M.D., Ph.D., Jarrett Revels, and Jacob A. Donoghue.
JA
Jacob A. Donoghue, M.D., Ph.D.Co-founder
JR
Jarrett RevelsCo-founder
JA
Jacob A. DonoghueCo-founder
Board
CD
Caitlin DonovanBoard director
PR
Pavel RaifeldBoard director
NR
Naveen RaoBoard director
Investors · 8
Catalio Capital Management, LPNew York
.png)
General CatalystSan Francisco · $30Mvia Hemant Taneja · quoted
GV (Google Ventures)Mountain View · $250K – $50M
Iaso VenturesCambridge
Kicker VenturesMenlo Park · $100K – $1Mvia Masashi Kiyomine · inferred
Casdin CapitalreportedNew York
Indicator VenturesreportedNew York · $1M – $3M
Samsung NextreportedSan Jose · $100K – $5M
Reported raises · per SEC filings
Form D private placements$133.2M disclosed across 3 rounds · 2019–2025
▶$103.3MraisedApr 2026 · 43 investors · Other TechnologyRule 506(b)
▶$103.3MraisedApr 2026 · 43 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Caitlin DonovanDirector
- Pavel RaifeldDirector
- Jacob A. Donoghue, M.D., Ph.D.Executive Officer, Director
- Jarrett RevelsExecutive Officer
- Naveen RaoDirector
- Offering amount
- $103.3M
- Amount sold
- $103.3M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$29.9MraisedOct 2021 · 42 investors · Other TechnologyRule 506(b)
▶$29.9MraisedOct 2021 · 42 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Naveen RaoDirector
- Jacob A. DonoghueExecutive Officer, Director
- Jarrett RevelsExecutive Officer
- Offering amount
- $29.9M
- Amount sold
- $29.9M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$50KraisedFeb 2019 · 1 investors · Other TechnologyRule 506(b)
▶$50KraisedFeb 2019 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jacob A. DonoghueExecutive Officer, Director, Promoter
- Naveen RaoDirector
- Jarrett RevelsExecutive Officer, Promoter
- Offering amount
- $1.6M
- Amount sold
- $50K
- Minimum investment
- $10K
- Proceeds to insiders
- $100K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Beacon Biosignals?
- Beacon Biosignals was founded by Jacob A. Donoghue, M.D., Ph.D., Jarrett Revels, Jacob A. Donoghue in 2019.
- Who are Beacon Biosignals's investors?
- Beacon Biosignals's investors include Catalio Capital Management, LP, General Catalyst, GV (Google Ventures), Iaso Ventures, Kicker Ventures, Casdin Capital, Indicator Ventures, Samsung Next.
- How much funding has Beacon Biosignals raised?
- Beacon Biosignals has disclosed $133.2M raised across 3 rounds.
- Where is Beacon Biosignals headquartered?
- Beacon Biosignals is headquartered in Boston, US.